Free Trial

The Cigna Group (CI) Competitors

The Cigna Group logo
$276.92 +2.12 (+0.77%)
(As of 12/20/2024 05:31 PM ET)

CI vs. ELV, HUM, CNC, MOH, UNH, OSCR, TRUP, ALHC, CLOV, and BHG

Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Humana (HUM), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Trupanion (TRUP), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), and Bright Health Group (BHG). These companies are all part of the "hospital & medical service plans" industry.

The Cigna Group vs.

The Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 2.0%. Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.8%. The Cigna Group pays out 52.8% of its earnings in the form of a dividend. Elevance Health pays out 23.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years.

87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 0.4% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

The Cigna Group presently has a consensus price target of $394.64, indicating a potential upside of 42.51%. Elevance Health has a consensus price target of $539.20, indicating a potential upside of 47.34%. Given Elevance Health's higher possible upside, analysts clearly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Cigna Group
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
3.00
Elevance Health
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.81

The Cigna Group has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

Elevance Health has a net margin of 3.68% compared to The Cigna Group's net margin of 1.31%. Elevance Health's return on equity of 19.56% beat The Cigna Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Cigna Group1.31% 18.42% 5.10%
Elevance Health 3.68%19.56%7.22%

The Cigna Group received 91 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 72.44% of users gave The Cigna Group an outperform vote while only 67.21% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
The Cigna GroupOutperform Votes
954
72.44%
Underperform Votes
363
27.56%
Elevance HealthOutperform Votes
863
67.21%
Underperform Votes
421
32.79%

Elevance Health has lower revenue, but higher earnings than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Cigna Group$229.75B0.34$5.16B$10.6026.12
Elevance Health$174.02B0.49$5.99B$27.4313.34

In the previous week, The Cigna Group and The Cigna Group both had 16 articles in the media. The Cigna Group's average media sentiment score of 0.66 beat Elevance Health's score of 0.49 indicating that The Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Cigna Group
9 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Elevance Health beats The Cigna Group on 11 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricThe Cigna GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$77.03B$59.06B$5.06B$19.18B
Dividend Yield2.11%1.78%4.84%3.58%
P/E Ratio26.1219.87102.6741.22
Price / Sales0.340.561,121.7417.58
Price / Cash8.218.8841.3021.28
Price / Book1.754.504.745.32
Net Income$5.16B$3.04B$119.11M$989.67M
7 Day Performance-1.75%-6.30%-1.86%-3.45%
1 Month Performance-16.26%-11.63%11.37%-3.73%
1 Year Performance-6.86%21.16%30.22%12.06%

The Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CI
The Cigna Group
4.9978 of 5 stars
$276.92
+0.8%
$394.64
+42.5%
-6.5%$77.03B$229.75B26.1272,500High Trading Volume
ELV
Elevance Health
4.8483 of 5 stars
$376.14
-1.4%
$539.20
+43.4%
-20.3%$87.23B$171.34B13.90104,900Analyst Downgrade
Analyst Revision
HUM
Humana
4.695 of 5 stars
$268.05
-2.2%
$304.15
+13.5%
-45.3%$32.28B$106.37B24.2867,600Analyst Forecast
CNC
Centene
4.9269 of 5 stars
$59.12
-0.5%
$81.31
+37.5%
-17.5%$29.85B$161.73B10.3267,700Analyst Forecast
Insider Trade
MOH
Molina Healthcare
4.8612 of 5 stars
$297.95
-1.7%
$367.17
+23.2%
-16.2%$17.04B$39.20B15.39123,123Analyst Forecast
UNH
UnitedHealth Group
4.9919 of 5 stars
$505.02
-3.0%
$626.84
+24.1%
-3.1%$464.76B$389.07B33.61440,000
OSCR
Oscar Health
2.8693 of 5 stars
$13.78
+0.9%
$21.56
+56.5%
+74.8%$3.41B$5.86B0.002,400
TRUP
Trupanion
1.2412 of 5 stars
$54.17
+2.7%
$44.67
-17.5%
+60.5%$2.29B$1.24B-164.781,142
ALHC
Alignment Healthcare
0.6999 of 5 stars
$11.46
+0.1%
$11.44
-0.1%
+31.6%$2.20B$2.47B-14.871,536
CLOV
Clover Health Investments
3.1995 of 5 stars
$3.21
+3.2%
$4.00
+24.6%
+229.6%$1.61B$2.12B-15.55552Analyst Forecast
BHG
Bright Health Group
N/A$5.16
+3.0%
N/A-24.2%$41.19M$2.76B-0.022,840Gap Down

Related Companies and Tools


This page (NYSE:CI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners